Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2h-pyrimidino(6,1-a)isoquinolin-4-one
2. Rpl 554
3. Rpl-554
4. Rpl554
1. Rpl-554
2. 298680-25-8
3. Rpl554
4. 1884461-72-6
5. Ensifentrine [inn]
6. Ensifentrine [usan]
7. Ls-193855
8. 3e3d8t1gix
9. Ls-193,855
10. A]isoquinolin-3(4h)-yl}ethyl)urea
11. (e)-1-(2-(2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2h-pyrimido[6,1-a]isoquinolin-3(4h)-yl)ethyl)urea
12. 2-[9,10-dimethoxy-4-oxo-2-(2,4,6-trimethylphenyl)imino-6,7-dihydropyrimido[6,1-a]isoquinolin-3-yl]ethylurea
13. Trimethylphenyl)imino]-6,7-dihydro-2h-pyrimido[6,1-
14. N-(2-{(2e)-9,10-dimethoxy-4-oxo-2-[(2,4,6-
15. 2-(9,10-dimethoxy-4-oxo-2-(2,4,6-trimethylphenyl)imino-6,7-dihydropyrimido(6,1-a)isoquinolin-3-yl)ethylurea
16. N-(2-((2e)-9,10-dimetoxi-4-oxo-2-((2,4,6-trimetilfenil)imino)-6,7-dihidro-2h-pirimido(6,1-a)isoquinolein-3(4h)-il)etil)urea
17. Urea, N-(2-(6,7-dihydro-9,10-dimethoxy-4-oxo-2-((2,4,6-trimethylphenyl)imino)-2h-pyrimido(6,1-a)isoquinolin-3(4h)-yl)ethyl)-
18. Unii-3e3d8t1gix
19. Vmx-554
20. Rpl-554;ensifentrinum
21. Ensifentrine (usan/inn)
22. Ensifentrine [who-dd]
23. Schembl625876
24. Chembl4594287
25. Schembl20720900
26. Gtpl11865
27. Dtxsid00183983
28. Bcp31840
29. Ex-a6633
30. Who 10726
31. Sb19810
32. D11743
33. A937318
34. Q7277486
35. Ensifentrina; Ensifentrinum;rpl-554;rpl554;rpl 554
36. 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2h-pyrimidino(6,1-a)isoquinolin-4-one
37. 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2h-pyrimido[6,1-a]isoquinolin-4-one
38. 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2h-pyrimido[6,1-a]isoquinolin-4-one
39. 9,10-dimethoxy-2-(2.4.6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2h-pyrimido[6.1-a]isoquinolin-4-one
Molecular Weight | 477.6 g/mol |
---|---|
Molecular Formula | C26H31N5O4 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 477.23760449 g/mol |
Monoisotopic Mass | 477.23760449 g/mol |
Topological Polar Surface Area | 110 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 849 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
65
PharmaCompass offers a list of Ensifentrine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ensifentrine manufacturer or Ensifentrine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ensifentrine manufacturer or Ensifentrine supplier.
PharmaCompass also assists you with knowing the Ensifentrine API Price utilized in the formulation of products. Ensifentrine API Price is not always fixed or binding as the Ensifentrine Price is obtained through a variety of data sources. The Ensifentrine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ensifentrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ensifentrine, including repackagers and relabelers. The FDA regulates Ensifentrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ensifentrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ensifentrine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ensifentrine supplier is an individual or a company that provides Ensifentrine active pharmaceutical ingredient (API) or Ensifentrine finished formulations upon request. The Ensifentrine suppliers may include Ensifentrine API manufacturers, exporters, distributors and traders.
click here to find a list of Ensifentrine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ensifentrine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ensifentrine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ensifentrine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ensifentrine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ensifentrine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ensifentrine suppliers with NDC on PharmaCompass.
Ensifentrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ensifentrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ensifentrine GMP manufacturer or Ensifentrine GMP API supplier for your needs.
A Ensifentrine CoA (Certificate of Analysis) is a formal document that attests to Ensifentrine's compliance with Ensifentrine specifications and serves as a tool for batch-level quality control.
Ensifentrine CoA mostly includes findings from lab analyses of a specific batch. For each Ensifentrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ensifentrine may be tested according to a variety of international standards, such as European Pharmacopoeia (Ensifentrine EP), Ensifentrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ensifentrine USP).